Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilins with their pharmacologic activity measured by the mixed-lymphocyte culture assay-Reference-Cited by-同舟云学术

Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilins with their pharmacologic activity measured by the mixed-lymphocyte culture assay

Published:1996-08 Issue:4 Volume:29 Page:309-313
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Goodyear Nancy,Murthy Jayasimha N.,Gallant Heather L.,Yatscoff Randall W.,Soldin Steven J.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference27 articles.

1. Rapamycin (AY-22,989), a new antifungal antibiotic: I. Taxonomy of the producing streptomycete and isolate of the active principle;Vezina;J Antibiot,1975

2. FK-506, a novel immunosuppressant isolated from a Streptomyces II. Immunosuppressive effect of FK-506 in vitro;Kino;J Antibiot,1987

3. Rapamune (Sirolimus, rapamycin): An overview and mechanism of action;Seghal;Ther Drug Monit,1995

4. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells;Dumont;J Immunol,1990

5. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin;Kahan;Trans,1991

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus;Clinical Pharmacokinetics;2005

2. Stent-based antirestenotic coatings (sirolimus/paclitaxel);Catheterization and Cardiovascular Interventions;2002-02-21

3. From Beach to Bedside: History of the Development of Sirolimus;Therapeutic Drug Monitoring;2001-10

4. Clinical Pharmacokinetics of Sirolimus;Clinical Pharmacokinetics;2001

5. New Immunosuppressive Agents;Cardiac Allograft Rejection;2001